SARTORIUS AG (SRT.DE) Stock Fundamental Analysis
Europe - FRA:SRT - DE0007165607 - Common Stock
190.4 EUR
+1.6 (+0.85%)
Taking everything into account, SRT scores 3 out of 10 in our fundamental rating. SRT was compared to 20 industry peers in the Life Sciences Tools & Services industry. Both the profitability and financial health of SRT have multiple concerns. While showing a medium growth rate, SRT is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year SRT was profitable.
In the past year SRT had a positive cash flow from operations.
SRT had positive earnings in each of the past 5 years.
In the past 5 years SRT always reported a positive cash flow from operatings.
1.2 Ratios
SRT's Return On Assets of 1.39% is on the low side compared to the rest of the industry. SRT is outperformed by 70.00% of its industry peers.
With a Return On Equity value of 5.01%, SRT is not doing good in the industry: 65.00% of the companies in the same industry are doing better.
SRT has a worse Return On Invested Capital (4.71%) than 65.00% of its industry peers.
SRT had an Average Return On Invested Capital over the past 3 years of 8.34%. This is in line with the industry average of 7.43%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.39% | ||
| ROE | 5.01% | ||
| ROIC | 4.71% |
ROA(3y)4.22%
ROA(5y)4.59%
ROE(3y)15.69%
ROE(5y)18.55%
ROIC(3y)8.34%
ROIC(5y)10.45%
1.3 Margins
The Profit Margin of SRT (3.80%) is worse than 70.00% of its industry peers.
SRT's Profit Margin has declined in the last couple of years.
SRT has a Operating Margin (14.06%) which is in line with its industry peers.
SRT's Operating Margin has declined in the last couple of years.
SRT has a Gross Margin of 46.48%. This is in the better half of the industry: SRT outperforms 75.00% of its industry peers.
SRT's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.06% | ||
| PM (TTM) | 3.8% | ||
| GM | 46.48% |
OM growth 3Y-21.14%
OM growth 5Y-7.77%
PM growth 3Y-35.47%
PM growth 5Y-21.95%
GM growth 3Y-5.43%
GM growth 5Y-2.63%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so SRT is still creating some value.
Compared to 1 year ago, SRT has more shares outstanding
SRT has more shares outstanding than it did 5 years ago.
SRT has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.10 indicates that SRT is not a great score, but indicates only limited risk for bankruptcy at the moment.
SRT has a worse Altman-Z score (2.10) than 65.00% of its industry peers.
The Debt to FCF ratio of SRT is 8.92, which is on the high side as it means it would take SRT, 8.92 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 8.92, SRT is in line with its industry, outperforming 45.00% of the companies in the same industry.
SRT has a Debt/Equity ratio of 1.28. This is a high value indicating a heavy dependency on external financing.
SRT's Debt to Equity ratio of 1.28 is on the low side compared to the rest of the industry. SRT is outperformed by 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.28 | ||
| Debt/FCF | 8.92 | ||
| Altman-Z | 2.1 |
ROIC/WACC0.62
WACC7.6%
2.3 Liquidity
A Current Ratio of 0.95 indicates that SRT may have some problems paying its short term obligations.
The Current ratio of SRT (0.95) is worse than 80.00% of its industry peers.
SRT has a Quick Ratio of 0.95. This is a bad value and indicates that SRT is not financially healthy enough and could expect problems in meeting its short term obligations.
SRT has a Quick ratio of 0.49. This is amonst the worse of the industry: SRT underperforms 85.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.95 | ||
| Quick Ratio | 0.49 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 59.34% over the past year.
SRT shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -11.87% yearly.
SRT shows a small growth in Revenue. In the last year, the Revenue has grown by 5.82%.
Measured over the past years, SRT shows a quite strong growth in Revenue. The Revenue has been growing by 13.10% on average per year.
EPS 1Y (TTM)59.34%
EPS 3Y-36.07%
EPS 5Y-11.87%
EPS Q2Q%24.14%
Revenue 1Y (TTM)5.82%
Revenue growth 3Y-0.67%
Revenue growth 5Y13.1%
Sales Q2Q%6.25%
3.2 Future
Based on estimates for the next years, SRT will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.16% on average per year.
Based on estimates for the next years, SRT will show a quite strong growth in Revenue. The Revenue will grow by 8.92% on average per year.
EPS Next Y23.27%
EPS Next 2Y20.61%
EPS Next 3Y22.38%
EPS Next 5Y19.16%
Revenue Next Year5.14%
Revenue Next 2Y7.17%
Revenue Next 3Y8.54%
Revenue Next 5Y8.92%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 41.75, the valuation of SRT can be described as expensive.
SRT's Price/Earnings ratio is a bit more expensive when compared to the industry. SRT is more expensive than 70.00% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.10, SRT is valued quite expensively.
The Price/Forward Earnings ratio is 31.94, which means the current valuation is very expensive for SRT.
65.00% of the companies in the same industry are cheaper than SRT, based on the Price/Forward Earnings ratio.
SRT's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 22.52.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 41.75 | ||
| Fwd PE | 31.94 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SRT is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, SRT is valued a bit cheaper than 70.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 29.79 | ||
| EV/EBITDA | 19.56 |
4.3 Compensation for Growth
SRT's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as SRT's earnings are expected to grow with 22.38% in the coming years.
PEG (NY)1.79
PEG (5Y)N/A
EPS Next 2Y20.61%
EPS Next 3Y22.38%
5. Dividend
5.1 Amount
SRT has a yearly dividend return of 0.39%, which is pretty low.
SRT's Dividend Yield is comparable with the industry average which is at 0.71.
Compared to an average S&P500 Dividend Yield of 2.37, SRT's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.39% |
5.2 History
The dividend of SRT has a limited annual growth rate of 3.71%.
Dividend Growth(5Y)3.71%
Div Incr Years3
Div Non Decr Years3
5.3 Sustainability
37.92% of the earnings are spent on dividend by SRT. This is a low number and sustainable payout ratio.
The dividend of SRT is growing, but earnings are growing more, so the dividend growth is sustainable.
DP37.92%
EPS Next 2Y20.61%
EPS Next 3Y22.38%
FRA:SRT (10/31/2025, 7:00:00 PM)
190.4
+1.6 (+0.85%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners4.37%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap14.26B
Revenue(TTM)3.52B
Net Income(TTM)133.70M
Analysts80
Price Target269.28 (41.43%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.39% |
Yearly Dividend0.74
Dividend Growth(5Y)3.71%
DP37.92%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.85%
Min EPS beat(2)-10.52%
Max EPS beat(2)4.83%
EPS beat(4)1
Avg EPS beat(4)-3.47%
Min EPS beat(4)-10.52%
Max EPS beat(4)4.83%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.05%
Min Revenue beat(2)-0.73%
Max Revenue beat(2)0.83%
Revenue beat(4)3
Avg Revenue beat(4)1.91%
Min Revenue beat(4)-0.73%
Max Revenue beat(4)4.87%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.45%
PT rev (3m)-7.37%
EPS NQ rev (1m)3.45%
EPS NQ rev (3m)3.45%
EPS NY rev (1m)0%
EPS NY rev (3m)0.3%
Revenue NQ rev (1m)2.71%
Revenue NQ rev (3m)2.71%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.47%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 41.75 | ||
| Fwd PE | 31.94 | ||
| P/S | 4.05 | ||
| P/FCF | 29.79 | ||
| P/OCF | 16.31 | ||
| P/B | 5.34 | ||
| P/tB | N/A | ||
| EV/EBITDA | 19.56 |
EPS(TTM)4.56
EY2.39%
EPS(NY)5.96
Fwd EY3.13%
FCF(TTM)6.39
FCFY3.36%
OCF(TTM)11.68
OCFY6.13%
SpS46.97
BVpS35.63
TBVpS-35.24
PEG (NY)1.79
PEG (5Y)N/A
Graham Number60.46
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.39% | ||
| ROE | 5.01% | ||
| ROCE | 6.33% | ||
| ROIC | 4.71% | ||
| ROICexc | 4.98% | ||
| ROICexgc | 17.77% | ||
| OM | 14.06% | ||
| PM (TTM) | 3.8% | ||
| GM | 46.48% | ||
| FCFM | 13.61% |
ROA(3y)4.22%
ROA(5y)4.59%
ROE(3y)15.69%
ROE(5y)18.55%
ROIC(3y)8.34%
ROIC(5y)10.45%
ROICexc(3y)8.77%
ROICexc(5y)11.17%
ROICexgc(3y)24.37%
ROICexgc(5y)31.52%
ROCE(3y)11.22%
ROCE(5y)14.06%
ROICexgc growth 3Y-35.26%
ROICexgc growth 5Y-11.95%
ROICexc growth 3Y-38.49%
ROICexc growth 5Y-19.53%
OM growth 3Y-21.14%
OM growth 5Y-7.77%
PM growth 3Y-35.47%
PM growth 5Y-21.95%
GM growth 3Y-5.43%
GM growth 5Y-2.63%
F-Score7
Asset Turnover0.37
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.28 | ||
| Debt/FCF | 8.92 | ||
| Debt/EBITDA | 3.69 | ||
| Cap/Depr | 92.32% | ||
| Cap/Sales | 11.25% | ||
| Interest Coverage | 2.65 | ||
| Cash Conversion | 94.72% | ||
| Profit Quality | 357.97% | ||
| Current Ratio | 0.95 | ||
| Quick Ratio | 0.49 | ||
| Altman-Z | 2.1 |
F-Score7
WACC7.6%
ROIC/WACC0.62
Cap/Depr(3y)148.03%
Cap/Depr(5y)150.65%
Cap/Sales(3y)13.71%
Cap/Sales(5y)12.64%
Profit Quality(3y)282.77%
Profit Quality(5y)224.27%
High Growth Momentum
Growth
EPS 1Y (TTM)59.34%
EPS 3Y-36.07%
EPS 5Y-11.87%
EPS Q2Q%24.14%
EPS Next Y23.27%
EPS Next 2Y20.61%
EPS Next 3Y22.38%
EPS Next 5Y19.16%
Revenue 1Y (TTM)5.82%
Revenue growth 3Y-0.67%
Revenue growth 5Y13.1%
Sales Q2Q%6.25%
Revenue Next Year5.14%
Revenue Next 2Y7.17%
Revenue Next 3Y8.54%
Revenue Next 5Y8.92%
EBIT growth 1Y18.65%
EBIT growth 3Y-21.66%
EBIT growth 5Y4.31%
EBIT Next Year99.69%
EBIT Next 3Y38.21%
EBIT Next 5Y26.49%
FCF growth 1Y123.33%
FCF growth 3Y7.25%
FCF growth 5Y29.73%
OCF growth 1Y6.61%
OCF growth 3Y4.07%
OCF growth 5Y20.79%
SARTORIUS AG / SRT.DE FAQ
What is the ChartMill fundamental rating of SARTORIUS AG (SRT.DE) stock?
ChartMill assigns a fundamental rating of 3 / 10 to SRT.DE.
Can you provide the valuation status for SARTORIUS AG?
ChartMill assigns a valuation rating of 2 / 10 to SARTORIUS AG (SRT.DE). This can be considered as Overvalued.
Can you provide the profitability details for SARTORIUS AG?
SARTORIUS AG (SRT.DE) has a profitability rating of 3 / 10.
What is the expected EPS growth for SARTORIUS AG (SRT.DE) stock?
The Earnings per Share (EPS) of SARTORIUS AG (SRT.DE) is expected to grow by 23.27% in the next year.
Can you provide the dividend sustainability for SRT stock?
The dividend rating of SARTORIUS AG (SRT.DE) is 4 / 10 and the dividend payout ratio is 37.92%.